BVS, Absorb stent, bioresorbable scaffold, ABSORB III data, ABSORB III results
Feature | Stents Bioresorbable | March 21, 2017 | Dave Fornell

 

March 21, 2017 — In the late-breaking ABSORB III Trial two year results presented at the American College...

Technology | Guidewires | March 20, 2017

March 20, 2017 — Teleflex Inc. recently announced 510(k) clearance by the U.S. Food and Drug Administration (FDA)...

Agfa HealthCare, Enterprise Imaging for Cardiology, ACC.17, IBM Watson Health
Technology | Enterprise Imaging | March 20, 2017

March 20, 2017 — Agfa HealthCare announced the release a new version of its...

Toshiba Medical, Aplio i900 cardiovascular ultrasound, FDA clearance, ACC 2017, RSNA 2017
Technology | Cardiovascular Ultrasound | March 20, 2017

March 20, 2017 — Cardiologists can now access the advanced...

iFR, iFR vs. FFR, ACC late breaking trial, iFR-SWEDEHEART, DEFINE-FLAIR, Justin E. Davies,

Matthias Götberg, principal investigator for the iFR-SWEDEHEART study, and Justin E. Davies, lead investigator for the DEFINE-FLAIR trial, share key points of their study with DAIC editor Dave Fornell at ACC.17. The trials showed iFR is equal in outcomes to FFR in assessing coronary lesions. 

Feature | FFR Catheters | March 20, 2017

March 20, 2017 — For patients experiencing angina (chest pain) or a heart attack, instantaneous wave-free ratio (iFR...

Evolocumab, Repatha, LDL, ACC late breaker, best LDL lowering drug
Feature | Pharmaceuticals | March 20, 2017

March 20, 2017 — The most important late-breaking pharmaceutical trial at the 2017 America College of Cardiology...

Michael Reardon, SURTAVI, TAVR equals surgery in intermediate risk patients

SURTAVI Trial principal investigator Michael Reardon presents the data as a lake-breaker at ACC 2017. 

News | Heart Valve Technology | March 17, 2017 | Dave Fornell

March 17, 2017 - Transcatheter aortic valve replacement (TAVR) was found to be noninferior to surgical aortic valve...

Gore Tigris Vascular Stent, Health Canada approval, PAD, peripheral artery disease
News | Stents Peripheral | March 16, 2017

March 16, 2017 — W. L. Gore & Associates Inc. recently announced the Health Canada approval of the Gore Tigris...

alcohol abuse, heart conditions, risk factors, JACC study, increased risk
News | Cardiac Diagnostics | March 16, 2017

March 16, 2017 — Alcohol abuse increases the risk of atrial fibrillation, heart attack and congestive heart failure...

Siemens Healthineers, ACC 2017, syngot CTO Guidance, Compressed Sensing Cardiac Cine
News | Cardiac Imaging | March 16, 2017

March 16, 2017 — During the 66th Annual Scientific Session & Expo of the American College of Cardiology (ACC),...

valve regurgitation, ASE, new guidelines, imaging, evaluation, SCMR, echocardiography, ultrasound, cardiac MRI
News | Cardiovascular Ultrasound | March 16, 2017

March 16, 2017 — A new document from the American Society of Echocardiography (ASE) provides a comprehensive update...

Medtronic, Reveal LINQ ICM, insertable cardiac monitor, FDA clearance, TruRhythm Detection
Technology | Implantable Cardiac Monitor (ICM) | March 15, 2017

March 15, 2017 — Medtronic plc announced U.S. Food and Drug Administration (FDA) 510(k) clearance for its Reveal...

Siemens Healthineers, Artis pheno angiography system, FDA approval, ACC 2017, RSNA 2017
Technology | Angiography | March 15, 2017

March 15, 2017 — The U.S. Food and Drug Administration (FDA) has cleared the Artis pheno robotic C-arm...

marijuana use, increased risk, stroke, heart failure, ACC 2017 study
News | Stroke | March 15, 2017

March 15, 2017 — Using marijuana raises the risk of...

Videos | Analytics Software | March 15, 2017

Pam Rush, RN, MS, clinical program director, cardiovascular service line, and Craig Strauss, M.D., MPH, medical...

Overlay Init